4.1. Analysis.
Comparison 4 Inotersen versus placebo in TTR‐FAP, Outcome 1 Severity of peripheral neuropathy (expressed as the change from baseline in the mNIS+7Ionis), at 66 weeks.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.